SVETLANA POLYAK: Open Payments
NPI 1164871745 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$127 in 5 payments from 4 companies in 2025. Trend: 2023 $156 · 2024 $152 · 2025 $127
Food & beverage: $127
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| Cipher Pharmaceuticals US LLC | 1 | $30 |
| Amgen Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, Natroba, KRYSTEXXA, REXULTI.
Industry payments across FL — which companies pay providers there.
